Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11181368rdf:typepubmed:Citationlld:pubmed
pubmed-article:11181368lifeskim:mentionsumls-concept:C0038170lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0007732lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C1955827lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:11181368lifeskim:mentionsumls-concept:C0965849lld:lifeskim
pubmed-article:11181368pubmed:issue3lld:pubmed
pubmed-article:11181368pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11181368pubmed:abstractTextRo 63-9141 is a new member of the pyrrolidinone-3-ylidenemethyl cephem series of cephalosporins. Its antibacterial spectrum was evaluated against significant gram-positive and gram-negative pathogens in comparison with those of reference drugs, including cefotaxime, cefepime, meropenem, and ciprofloxacin. Ro 63-9141 showed high antibacterial in vitro activity against gram-positive bacteria except ampicillin-resistant enterococci, particularly vancomycin-resistant strains of Enterococcus faecium. Its MIC at which 90% of the isolates tested were inhibited (MIC(90)) for methicillin-resistant Staphylococcus aureus (MRSA) was 4 microg/ml. Ro 63-9141 was bactericidal against MRSA. Development of resistance to the new compound in MRSA was not observed. Ro 63-9141 was more potent than cefotaxime against penicillin-resistant Streptococcus pneumoniae (MIC(90) = 2 microg/ml). It was active against ceftazidime-susceptible strains of Pseudomonas aeruginosa and against Enterobacteriaceae except Proteus vulgaris and some isolates producing extended-spectrum beta-lactamases. The basis for the antibacterial spectrum of Ro 63-9141 lies in its affinity to essential penicillin-binding proteins, including PBP 2' of MRSA, and its stability towards beta-lactamases. The in vivo findings were in accordance with the in vitro susceptibilities of the pathogens. These data suggest the potential utility of Ro 63-9141 for the therapy of infections caused by susceptible pathogens, including MRSA. Since insufficient solubility of Ro 63-9141 itself precludes parenteral administration in humans, a water-soluble prodrug, Ro 65-5788, is considered for development.lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:languageenglld:pubmed
pubmed-article:11181368pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:citationSubsetIMlld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11181368pubmed:statusMEDLINElld:pubmed
pubmed-article:11181368pubmed:monthMarlld:pubmed
pubmed-article:11181368pubmed:issn0066-4804lld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:RothRRlld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:AngehrnPPlld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:PageM GMGlld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:HohlPPlld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:HebeisenPPlld:pubmed
pubmed-article:11181368pubmed:authorpubmed-author:Heinze-Krauss...lld:pubmed
pubmed-article:11181368pubmed:issnTypePrintlld:pubmed
pubmed-article:11181368pubmed:volume45lld:pubmed
pubmed-article:11181368pubmed:ownerNLMlld:pubmed
pubmed-article:11181368pubmed:authorsCompleteYlld:pubmed
pubmed-article:11181368pubmed:pagination825-36lld:pubmed
pubmed-article:11181368pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:meshHeadingpubmed-meshheading:11181368...lld:pubmed
pubmed-article:11181368pubmed:year2001lld:pubmed
pubmed-article:11181368pubmed:articleTitleIn vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.lld:pubmed
pubmed-article:11181368pubmed:affiliationPharmaceutical Research, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.lld:pubmed
pubmed-article:11181368pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11181368lld:pubmed
More...